Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability
Description
Thrombosis has been associated with severity and mortality in COVID-19. SARS-CoV-2 infects the host via its spike protein. However, direct effects of spike proteins from SARS-CoV-2 variants on platelet activity and coagulability have not been
